Infra-low frequency transcranial magnetic stimulation as a therapy for generalized anxiety disorder: a randomized clinical trial

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000039472

Enrollment

Unknown

Registered

2020-10-28

Start date

2018-08-01

Completion date

Unknown

Last updated

2021-02-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Generalized Anxiety Disorder

Interventions

Active-ILF-TMS:Active-ILF-TMS over the whole brain

Sham- ILF-TMS:Sham- ILF-TMS

Eligibility

Sex/Gender

All

Age

18 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Clinical diagnosis of GAD according to DSM-5; (2) Aged from 18 to 60 years; (3) The Hamilton Anxiety Rating Scale (HAMA)>=14; (4) Patients being able to provide informed consent.

Exclusion criteria

Exclusion criteria: (1) Intracranial infection, tumor or metal objects; any metals in the body including pacemakers, stents, catheters, electrodes, cochlear implants; (2) Serious and/or unstable medical illness (for example encephaledema, cardiac disease, hemorrhagic disease); (3) Pregnancy; (4) Individuals being judged too psychiatrically unstable to participate (for example schizophrenia, affective disorder, acute suicidality); (5) Any other contraindication for rTMS (such as history of epilepsy).

Design outcomes

Primary

Measure	Time frame
HAMA;	—

Secondary

Measure	Time frame
HAMD;CGI;TESS;PVT;GO/ NO-GO;N-back Test;	—

Countries

China

Contacts

Public ContactBin Zhang?Meilei Su

Nanfang Hospital, Southern Medical University

zhang73bin@hotmail.com+86 13527807502

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026